Because ARL4C expression is induced by Wnt and EGF signaling, it is reasonable that ARL4C would be expressed in a β-catenin- and RAS-dependent manner in pancreatic cancer cells. The gene discussed is ARL4C; the disease is familial pancreatic carcinoma.